Illumina, Inc. ( ILMN) - Key Metrics
ILMN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $7.68 | $1.37 | $1.33 | $1.07 |
| 2026Q1 | $7.13 | $0.88 | $1.89 | $1.64 |
| 2025Q4 | $7.58 | $2.18 | $2.10 | $1.75 |
| 2025Q3 | $7.08 | $0.98 | $1.86 | $1.70 |
| 2025Q2 | $6.73 | $1.50 | $1.49 | $1.34 |
ILMN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 33.05 |
| 2026Q1 | 0% | 34.32 |
| 2025Q4 | 0% | 15.42 |
| 2025Q3 | 0% | 23.44 |
| 2025Q2 | 0% | 15.90 |
ILMN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.59% | 0% |
| 2026Q1 | 1.36% | 0% |
| 2025Q4 | 1.30% | 0% |
| 2025Q3 | 1.85% | 0% |
| 2025Q2 | 1.41% | 0% |
ILMN
Price: $269.42
52 week price:
Payout Ratio Range:
Earnings Per Share: 5.36 USD
P/E Ratio: 37.29
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1.1 million
Ebitda: 273.0 millionMarket Capitalization: 40.5 billion